98%
921
2 minutes
20
Background: Diagnosing infective endocarditis (IE) is a significant challenge. This study aimed to compare the diagnostic performance of the 2015 and 2023 European Society of Cardiology (ESC) and the 2023 International Society for Cardiovascular Infectious Diseases (ISCVID) Duke clinical criteria in a cohort of patients with suspected IE and intracardiac prosthetic material.
Methods: This retrospective study was conducted at 2 Swiss University Hospitals (2014-2024). The reference standard was the diagnosis of the Endocarditis Team or expert clinicians. Patients with IE (reference standard) classified as definite IE by the Duke criteria were considered true positives, while those without IE classified as rejected IE were considered true negatives.
Results: Of the 1025 episodes with suspected IE and intracardiac prosthetic material, 537 (61%) had IE. Using the 2015 ESC, 2023 ESC, and 2023 ISCVID clinical criteria, 324 (32%), 367 (36%), and 430 (42%) episodes were classified as definite IE, respectively. The sensitivity for the 2015 Duke-ESC, 2023 Duke-ESC, and 2023 Duke-ISCVID the clinical criteria was calculated to be 56% (95% CI: 52-60%), 61% (57-65%), and 71% (67-74%), respectively, while the specificity 67% (63-71%), 56% (51-61%), and 34% (29-38%), respectively.
Conclusions: The 2023 ISCVID Duke clinical criteria demonstrated the highest sensitivity for diagnosing IE compared to the 2015 and 2023 ESC Duke criteria in patients with intracardiac prosthetic material. However, this was at the expense of specificity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12404897 | PMC |
http://dx.doi.org/10.1093/ofid/ofaf507 | DOI Listing |
Open Forum Infect Dis
September 2025
Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Background: Diagnosing infective endocarditis (IE) is a significant challenge. This study aimed to compare the diagnostic performance of the 2015 and 2023 European Society of Cardiology (ESC) and the 2023 International Society for Cardiovascular Infectious Diseases (ISCVID) Duke clinical criteria in a cohort of patients with suspected IE and intracardiac prosthetic material.
Methods: This retrospective study was conducted at 2 Swiss University Hospitals (2014-2024).
Background Infective endocarditis (IE) is a life-threatening infection of the endocardial surface, most commonly affecting native or prosthetic valves and intracardiac devices. Despite advancements in diagnosis and treatment, IE continues to carry a high mortality risk. Blood cultures remain a cornerstone of diagnosis, typically yielding positive results and enabling identification of the causative organisms.
View Article and Find Full Text PDFInt J Cardiovasc Imaging
August 2025
Royal Brompton Hospital and Imperial College London, Bambino Gesù Hospital Rome, Rome, Italia.
Infective endocarditis is a complex disease leading to significant morbidity and mortality. The in-hospital mortality has remained at 15-30% despite significant advances in cardiac imaging over the past two decades. Prevention, timely diagnosis, and prompt treatment can minimise adverse sequelae.
View Article and Find Full Text PDFRev Cardiovasc Med
June 2025
Department of Cardiology, General Hospital Paphos, State Health Services Organization, 8026 Paphos, Cyprus.
Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure to treat severe aortic stenosis in select patients. Patients who have undergone TAVI are at high risk of infective endocarditis (IE), especially during the first year post-operation. Early diagnosis of IE is essential to initiate targeted antibiotic therapy and/or surgical intervention.
View Article and Find Full Text PDFOpen Heart
June 2025
Infectious Diseases, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain
Background: The definition of early prosthetic valve endocarditis (PVE) remains controversial. This study aims to refine the definition of early PVE by analysing data from the Spanish endocarditis registry (Spanish Collaboration on Endocarditis).
Methods: From 2008 to 2022, 1305 consecutive cases of PVE were included.